このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
下肢表面性血栓炎の治療
Marcello Di Nisio1, Iris Wichers2, Saskia Middeldorp1
1Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, the Netherlands.
JAMA
|November 2, 2018
PubMed で要約を見る
まとめ
表面性血栓炎 (ST) の患者では,出血が増加することなく,ファンダパリヌックスは症状を伴う静脈性血栓栓症 (VTE) を有意に減少させる. 低分子量ヘパリンとNSAIDsは,ST拡張を防ぐのに役立ちますが,VTEデータは不確実です.
科学分野:
- 血管医学
- 薬理学について
- クリニカル・トランボシス
背景:
- 表面性血栓炎 (ST) は,表面性静脈の炎症と凝固を伴う状態である.
- 静脈血栓症 (VTE) は,STの潜在的な合併症である.
- 静脈動脈炎のリスクを最小限に抑えるための最適の治療戦略は明確化が必要です.
研究 の 目的:
- 下肢表面性血栓炎 (ST) の治療法を評価する.
- 様々なST治療とプラセボに関連した静脈性血栓塞栓事件 (VTE) の割合を比較する.
主な方法:
- ST治療とプラセボを比較したランダム化比較試験の体系的レビューとメタ分析.
- ファンダパリヌックス,低分子量ヘパリン (LMWH),非ステロイド抗炎症薬 (NSAIDs),および経口リバロキサバンを評価した研究を含む.
主要な成果:
- プラセボと比較して,症状のあるVTEが少なく,大出血の有意な増加は認められませんでした.
- 低分子量ヘパリン (LMWH) と非ステロイド性抗炎症薬 (NSAIDs) は,プラセボと比較して,ST延長または再発率が低いことを示した.
- LMWHとNSAIDが症状性VTEの発生率に及ぼす影響に関する証拠は,まだ定かではありません.
関連する概念動画
Absolute and Local Extreme Values
74
The highest and lowest values of a function, relative to a reference axis, are known as extreme values. These include absolute maximum and absolute minimum values, which represent the highest and lowest points the function reaches across its entire domain. Within a restricted portion of the function, the highest and lowest values are referred to as local maximum and local minimum values, respectively.Periodic functions, such as sine and cosine, show extreme values at infinitely many points due...
74
Open Angle Glaucoma: Treatment
997
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
997
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
952
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
952
Anticholinesterase Agents: Poisoning and Treatment
1.6K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.6K


